Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
28 juin 2018 12h01 HE
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20 juin 2018 12h03 HE
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27 févr. 2018 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30 janv. 2018 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors
11 janv. 2018 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18 déc. 2017 09h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15 nov. 2017 10h15 HE
|
PCI Synthesis
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Wins Big at 2017 Life Science Leader Magazine CMO Leadership Awards
23 mars 2017 09h14 HE
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 23, 2017) - PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other...
PCI Synthesis picks up Life Science CMO Leaderships Awards in all six categories
01 févr. 2017 09h11 HE
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Feb 1, 2017) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2017
19 déc. 2016 09h16 HE
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 19, 2016) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...